Invention Grant
- Patent Title: Compositions and methods for measles virus inhibition
-
Application No.: US14711364Application Date: 2015-05-13
-
Publication No.: US09725487B2Publication Date: 2017-08-08
- Inventor: Robert F. Garry , Russell B. Wilson
- Applicant: The Administrators of the Tulane Educational Fund
- Applicant Address: US LA New Orleans US LA New Orleans
- Assignee: The Administrators of the Tulane Educational Fund,Autoimmune Technologies, LLC
- Current Assignee: The Administrators of the Tulane Educational Fund,Autoimmune Technologies, LLC
- Current Assignee Address: US LA New Orleans US LA New Orleans
- Agency: Olson & Cepuritis, Ltd.
- Main IPC: C07K14/005
- IPC: C07K14/005 ; A61K38/04 ; A61K38/16 ; C07K7/00 ; C07K7/08 ; C12Q1/18 ; C07K7/06 ; G01N33/569 ; C12N7/00 ; A61K38/00
Abstract:
The present invention provides compositions and methods for treating a measles virus infection. A pharmaceutical composition comprises a polypeptide in a biocompatible pharmaceutical carrier, in which the polypeptide consists of at least a portion of SEQ ID NO: 5 or SEQ ID NO: 6. A method embodiment comprises administering the polypeptide (preferably in a biocompatible pharmaceutical carrier) to a subject suffering from a measles infection.
Public/Granted literature
- US20150239940A1 COMPOSITIONS AND METHODS FOR VIRUS INHIBITION Public/Granted day:2015-08-27
Information query
